Advertisement

Supply Chain



The U.S. Supreme Court on Monday sided with Bristol-Myers Squibb in a case that could make it more difficult for patients to sue major corporations in state courts over injuries caused by the companies' products, reports Politico.

Sanofi CEO Olivier Brandicourt, MD, shared his initial thoughts on the U.S. Supreme Court's recent decision to accelerate the launch of new biosimilars during the Viva Technology forum June 15-17 in Paris, reports Reuters.

Advertisement

Most Read

Advertisement
Advertisement